Navigation Links
Europe's leading pharmacologists to meet in Manchester
Date:7/10/2008

Hundreds of leading pharmacologists and bioscientists from across Europe will be in Manchester next week for the 5th Congress of the Federation of European Pharmacological Societies.

Hosted by the British Pharmacological Society, EPHAR 2008 has a packed programme of plenary lectures, cutting-edge symposia with subject-leading speakers as well as satellite meetings and trade exhibitions.

The four-day meeting, starting Monday, 14 July, will showcase the research of leading scientists from EPHAR's 24 affiliated pharmacological societies and promises to be the most important international pharmacological event of the year.

Key themes include reducing risk in drug discovery and development, respiratory pharmacology, pain and inflammation and pulmonary and cardiovascular pharmacology.

The Congress will close on Thursday, 17 July, with a debate-provoking lecture on Drug provision for the Developing World by world-renowned political philosopher, Professor Thomas Pogge.


'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1

Related medicine news :

1. CPC Hand-Delivers Patient Testimonies to State Leaders Pleading for No Budget Cuts to Health and Human Services
2. U.S. Preventive Medicine Applauds Leading Health Organizations for Disease Prevention Platforms
3. Leading Plastic Surgeons Reveal Revolution in Stem Cell Research Has its Roots in Beverly Hills Plastic Surgery
4. Leading worldwide cause of cardiovascular disease may be modified by diet
5. Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet
6. Leading Vaccine Expert Joins IAVI
7. Leading Eating Disorder Treatment Center Identifies Popular Diet Myths
8. Chinas Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
9. Leading Provider of Electronic Medical Records (EMR) Systems for Sleep Centers Adds Field Sales Representative
10. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
11. Leading Fertility Center Adds New Physician
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Kenneth Cochran, DSc, RN, FACHE, ... of the South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular ... Ultrasound Guided Coronary Atherectomy. , This procedure involves the removal of ...
(Date:5/5/2016)... CA (PRWEB) , ... May 05, 2016 , ... TransWipe ... Final Cut Pro X. Drag and drop a TransWipe preset between two video clips ... from smooth corner wipes to colored panels with customizable color and orientation options. TransWipe ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... (LAIs), today announced a development collaboration with the Australian critical medicine company, ... disorders such as schizophrenia. , LAI medicines can offer improved therapeutic benefits over ...
(Date:5/5/2016)... ... May 05, 2016 , ... Einstein Medical is proud to announce ... latest news and commentary at the 2016 ASCRS/ASOA Symposium and Congress, which takes place ... of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrations will be ...
(Date:5/5/2016)... ... ... Friday, May 6 - Sunday, May 8, fifteen elite athletes from Team Semper Fi ... Bike Camp, hosted in conjunction with WTB and Cannondale in Novato, ... share pro tips with the injured veterans as they rip down some of the best ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 5, 2016 ... of the  "Europe Systemic Lupus Erythematosus Market ... to their offering.       (Logo: ... latest research Europe Systemic Lupus Erythematosus Market ... comprehensive insights into Systemic Lupus Erythematosus pipeline ...
(Date:5/4/2016)... 2016  It,s time for an upgrade. There are many medical recorders on the ... LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a ... class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
Breaking Medicine Technology: